Oct 21, 2022
The alpha-1 antitrypsin deficiency (AATD) market is expected to reach USD 3 billion by 2032. The emerging landscape of the AATD treatment market appears promising, with novel therapies in the pipeline. Several key pharma and biotech giants, such as Mereo Biopharma, Kamada, and others, are actively working in the therapeutics segment.
Read More...
Oct 19, 2022
Several major innovations are going on in the Dental Care Market. Emerging trends and technologies like Teledentistry, 3D printing, 3D & Digital Dental X-Rays, Augmented Reality (AR) and Virtual Reality (VR), and others are immensely stimulating dental care management and treatment.
Read More...
Oct 17, 2022
More than 15 companies are conducting various trials for oncolytic viruses, among which ~ 30 assets in mid and late stage of development.
Read More...
Oct 14, 2022
As per DelveInsight, the checkpoint inhibitors market size is expected to skyrocket in coming years owing to the participation of companies.
Read More...
Oct 12, 2022
The Robotic Prosthetics Market is evolving at an immense pace. Several MedTech companies and startups are coming up with innovative solutions and devices
Read More...
Oct 10, 2022
Dynamics of PCSK9 inhibitors market are expected to change in the coming years. Several companies are also involved in therapeutics segment.
Read More...
Oct 07, 2022
The peripheral T-cell lymphoma treatment pipeline possesses potential drugs in mid-stage development and expected to launched in coming years.
Read More...
Oct 05, 2022
As per DelveInsight, the Vision Care Market is growing with the development of new products and devices. Eyewear, Intraocular Lenses (IOLS), Contact Lens Solutions driving the market
Read More...
Oct 03, 2022
Presently, the FDA-approved drugs available in the market for CTCL treatment include Istodax, Valchlor, Uvadex, Targretin, and others.
Read More...
Sep 28, 2022
Assistive technologies, such as hearing aids, cochlear implants, and other devices, are playing a key role in Hearing Loss management.
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper